- Home
- EQT vs ALC Comparison
EQT vs ALC Comparison
Compare EQT & ALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EQT
- ALC
- Stock Information
- Founded
- EQT 1925
- ALC 1945
- Country
- EQT United States
- ALC Switzerland
- Employees
- EQT N/A
- ALC N/A
- Industry
- EQT Oil & Gas Production
- ALC Ophthalmic Goods
- Sector
- EQT Energy
- ALC Health Care
- Exchange
- EQT Nasdaq
- ALC Nasdaq
- Market Cap
- EQT 33.9B
- ALC 40.2B
- IPO Year
- EQT N/A
- ALC N/A
- Fundamental
- Price
- EQT $55.95
- ALC $77.15
- Analyst Decision
- EQT Buy
- ALC Buy
- Analyst Count
- EQT 21
- ALC 11
- Target Price
- EQT $61.48
- ALC $95.55
- AVG Volume (30 Days)
- EQT 9.7M
- ALC 2.0M
- Earning Date
- EQT 10-21-2025
- ALC 11-11-2025
- Dividend Yield
- EQT 1.12%
- ALC 0.28%
- EPS Growth
- EQT 20.64
- ALC N/A
- EPS
- EQT 1.92
- ALC 2.16
- Revenue
- EQT $7,103,623,000.00
- ALC $10,025,000,000.00
- Revenue This Year
- EQT $71.22
- ALC $5.95
- Revenue Next Year
- EQT $20.71
- ALC $7.56
- P/E Ratio
- EQT $29.11
- ALC $35.55
- Revenue Growth
- EQT 60.31
- ALC 4.04
- 52 Week Low
- EQT $35.45
- ALC $73.22
- 52 Week High
- EQT $61.02
- ALC $99.30
- Technical
- Relative Strength Index (RSI)
- EQT 66.22
- ALC 48.36
- Support Level
- EQT $48.51
- ALC $73.22
- Resistance Level
- EQT $57.35
- ALC $77.50
- Average True Range (ATR)
- EQT 1.71
- ALC 1.04
- MACD
- EQT 0.56
- ALC 0.44
- Stochastic Oscillator
- EQT 80.20
- ALC 78.01
About EQT EQT Corporation
EQT is an independent natural gas production company. It focuses its operations in the cores of the Marcellus and Utica shales, located in the Appalachian Basin in the Eastern United States. Its main customers include marketers, utilities, and industrial operators in the Appalachian Basin. The company has three reportable segments in production, gathering, and its transmission segment, which is now an operated joint venture with Blackstone. All the firm's operating revenue is generated in the US, with most revenue flowing from the Marcellus Shale field and through the sale of natural gas.
About ALC Alcon Inc.
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.